biote Corp. (BTMD) financial statements and ratios from SEC XBRL: revenue $192.22M (TTM), net margin 14.1%, revenue growth -2.5% YoY, P/E 7.0. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $192.22M |
| Net Margin | 14.1% |
| Revenue Growth (YoY) | -2.5% |
| EPS Growth (YoY) | 855.6% |
| FCF Growth (YoY) | -22.2% |
| P/E Ratio | 7.0 |
| EV / EBITDA | 9.7 |
| Price / Sales | 0.25 |
| FCF Yield | 66.1% |
| DCF Value (model) | $78.35 |
| DCF Upside vs Price | 4751.4% |
| Altman Z-Score | 2.56 (grey) |
| Sector P/E (Healthcare) | 21.7 |
BTMD overview · BTMD earnings · BTMD KPIs · BTMD investor relations · BTMD ownership · BTMD peers · BTMD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.